During the last session, Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s traded shares were 0.43 million, with the beta value of the company hitting 1.91. At the end of the trading day, the stock’s price was $1.75, reflecting an intraday loss of -16.27% or -$0.34. The 52-week high for the CYCN share is $5.25, that puts it down -200.0 from that peak though still a striking 2.29% gain since the share price plummeted to a 52-week low of $1.71. The company’s market capitalization is $4.74M, and the average intraday trading volume over the past 10 days was 1.29 million shares, and the average trade volume was 214.28K shares over the past three months.
Cyclerion Therapeutics Inc (NASDAQ:CYCN) trade information
Cyclerion Therapeutics Inc (CYCN) registered a -16.27% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -16.27% in intraday trading to $1.75, hitting a weekly high. The stock’s 5-day price performance is -1.13%, and it has moved by -39.02% in 30 days. Based on these gigs, the overall price performance for the year is -32.80%. The short interest in Cyclerion Therapeutics Inc (NASDAQ:CYCN) is 14439.0 shares and it means that shorts have 0.78 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 36.06%.
CYCN Dividends
Cyclerion Therapeutics Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s Major holders
Cyclerion Therapeutics Inc insiders own 21.90% of total outstanding shares while institutional holders control 40.41%, with the float percentage being 51.74%.
Also, the Mutual Funds coming in first place with the largest holdings of Cyclerion Therapeutics Inc (CYCN) shares are Fidelity Select Portfolios – Biotechnology and Vanguard Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Fidelity Select Portfolios – Biotechnology owns about 38.31 shares. This amounts to just over 1.41 percent of the company’s overall shares, with a $67051.0 market value. The same data shows that the other fund manager holds slightly less at 23.49, or about 0.87% of the stock, which is worth about $41107.0.
